This stock is cheap, no doubt about it. It has very reliable...

This stock is cheap, no doubt about it. It has very reliable cash flow ( check out the last 5 years) . Issue was debt taken on during expansion , that turned sour.
Now with debt in the manageable range , with free cash for acquisition or a dividend, this looks a lot better.
With a operating cash flow steady at 24-25 million over the next 5 years, and reducing interest payments YOY , more money goes to the bottom line , increasing book value YOY.
very good turnaround story.
my two Health care stocks ( my other stock is CAJ at .90c) are in prime position to benefit from increasing need for imaging and VEI for eye related stuff. Ophthalmologists maintain a good restraint of trade, hence it is difficult to see operating income going down unless the govt really clamps down on a major income generating procedure. Usually YOY medicare funded surgeries and eye procedure costs will go up hence I see EBITDA increasing (albeit not by a huge margin).
One to hold imo